RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human tests begin for new RSV shot
⭐️ VACCINE ⭐️ Recruiting nowThis is an early-stage study to test the safety and body processing of a new vaccine injection, called SIBP-A16, designed to protect against Respiratory Syncytial Virus (RSV). It will involve 140 healthy adults who will receive different doses or a placebo. The main goal is to se…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
Extra shots for extra protection? RSV vaccine tested on vulnerable patients
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing the RSV vaccine Arexvy in people with weakened immune systems, such as organ transplant recipients. Researchers want to see if getting one or two doses provides a better immune response. Participants will receive vaccines over a year and report any side effe…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:39 UTC
-
Major trial tests new shot to protect seniors from dangerous RSV lung infections
⭐️ VACCINE ⭐️ Recruiting nowThis large, late-stage study is testing a new vaccine designed to protect adults aged 60 and older from serious lung diseases caused by Respiratory Syncytial Virus (RSV). About 25,000 participants will receive either the single-dose vaccine or a placebo to see if it safely preven…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 25, 2026 14:09 UTC
-
New safety check for RSV protection in vulnerable babies
Prevention Recruiting nowThis study is checking the safety of a medicine called palivizumab that helps prevent severe RSV lung infections in high-risk children. It involves 138 Indian infants and toddlers under 2 years old who were born very early, have chronic lung disease, or have serious heart conditi…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: NA • Sponsor: AstraZeneca • Aim: Prevention
Last updated Mar 30, 2026 14:31 UTC
-
Massive health study hunts 57 hidden diseases
Knowledge-focused Recruiting nowThis study aims to understand how 57 different infectious diseases spread in Cambodian communities. Researchers will survey 10,000 people and test their blood to see which diseases they have been exposed to. The goal is to gather information to help public health officials design…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC